We are live on ! Find out more
Point72 Asset Management

Point72 Asset Management Portfolio holdings

AUM $78.1B
1-Year Est. Return 55.25%
This Fund
S&P 500
This Quarter Est. Return
-19.6%
1 Year Est. Return
+55.25%
3 Year Est. Return
+151.79%
5 Year Est. Return
+188.05%
10 Year Est. Return
+800.63%
AUM
$20.5B
AUM Growth
-$3.77B
Cap. Flow
+$927M
Cap. Flow %
4.53%
Top 10 Hldgs %
10.43%
Holding
1,363
New
384
Increased
273
Reduced
250
Closed
441

Top Buys

Rank Stock Value
1
OVV icon
Ovintiv
OVV
+$223M
2
C icon
Citigroup
C
+$221M
3
BAX icon
Baxter International
BAX
+$212M
4
INGN icon
Inogen
INGN
+$208M
5
COP icon
ConocoPhillips
COP
+$193M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$150M
2
CMCSA icon
Comcast
CMCSA
+$145M
3
MPC icon
Marathon Petroleum
MPC
+$142M
4
CVX icon
Chevron
CVX
+$133M
5
AAPL icon
Apple
AAPL
+$125M

Sector Composition

Rank Sector Weight
1 Healthcare 20.23%
2 Consumer Discretionary 11.37%
3 Energy 11.05%
4 Technology 9.36%
5 Financials 8.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SKY icon
1176
Champion Homes
SKY
$4.41B
-50,000
Closed -$1.43M
SKX
1177
DELISTED
Skechers
SKX
-174,200
Closed -$4.87M
SLGN icon
1178
Silgan Holdings
SLGN
$4.51B
-45,300
Closed -$1.26M
SNA icon
1179
Snap-on
SNA
$21.5B
-28,105
Closed -$5.16M
SNAP icon
1180
CALL
Snap
SNAP
$7.96B
-124,900
Closed -$1.06M
SNAP icon
1181
PUT
Snap
SNAP
$7.96B
-3,242,200
Closed -$27.5M
SNDX icon
1182
Syndax Pharmaceuticals
SNDX
$1.7B
-170,000
Closed -$1.37M
SPGI icon
1183
S&P Global
SPGI
$124B
-39,000
Closed -$7.62M
SPRO icon
1184
Spero Therapeutics
SPRO
$68.9M
-44,000
Closed -$462K
SRE icon
1185
Sempra
SRE
$58.1B
-352,400
Closed -$20M
STLA icon
1186
Stellantis
STLA
$17.4B
-160,700
Closed -$2.81M
STNG icon
1187
Scorpio Tankers
STNG
$3.91B
-172,790
Closed -$3.47M
STZ icon
1188
CALL
Constellation Brands
STZ
$22.5B
-570,000
Closed -$123M
SUPN icon
1189
PUT
Supernus Pharmaceuticals
SUPN
$2.7B
-58,900
Closed -$2.97M
SVRA icon
1190
Savara
SVRA
$1.08B
-713,000
Closed -$7.96M
SYRE icon
1191
Spyre Therapeutics
SYRE
$8.5B
-10,625
Closed -$2.54M
T icon
1192
AT&T
T
$164B
-3,960,604
Closed -$92.2M
T icon
1193
PUT
AT&T
T
$164B
-1,721,200
Closed -$43.7M
TCBI icon
1194
Texas Capital Bancshares
TCBI
$4.28B
-17,200
Closed -$1.42M
TDG icon
1195
TransDigm Group
TDG
$70.7B
-16,100
Closed -$5.99M
TDOC icon
1196
Teladoc Health
TDOC
$1.66B
-49,554
Closed -$4.28M
TEL icon
1197
TE Connectivity
TEL
$60B
-62,076
Closed -$5.46M
TEVA icon
1198
Teva Pharmaceuticals
TEVA
$40.4B
-414,100
Closed -$8.92M
TEVA icon
1199
PUT
Teva Pharmaceuticals
TEVA
$40.4B
-600,000
Closed -$12.9M
THO icon
1200
CALL
Thor Industries
THO
$4.06B
-220,000
Closed -$18.4M

Similar funds

Point72 Asset Management's Q4 2018 Portfolio in Review

As of Q4 2018, Point72 Asset Management held 1,363 positions worth $20.5B, down 16% from $24.3B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Point72 Asset Management deployed $927M of net new capital in Q4 2018, opening 384 new positions and adding to 273 existing holdings. Its largest new stake was Citigroup: 3,496,120 shares worth $182M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Energy.

On the sell side, the largest reduction was Microsoft, an estimated $150M trimmed.

  • Point72 Asset Management's largest Q4 2018 buy was Citigroup: 3,496,120 shares worth $182M.
  • Point72 Asset Management added most to Ovintiv in Q4 2018, an estimated $223M increase.
  • Point72 Asset Management's biggest Q4 2018 reduction was Microsoft, cutting an estimated $150M.
  • Point72 Asset Management fully exited Royal Dutch Shell PLC ADS Class A in Q4 2018, selling an estimated $124M.
  • Point72 Asset Management's ten largest holdings make up 10% of its $20.5B portfolio in Q4 2018.
  • Point72 Asset Management opened 384 new positions and closed 441 in Q4 2018.
  • Point72 Asset Management's portfolio value fell 16% quarter-over-quarter to $20.5B.

Based on Point72 Asset Management's 13F filing for Q4 2018, filed 14 Feb 2019.